Altria Group has managed to surpass the Q4 earnings and revenue estimates and has a strong financial performance. The group acquired an additional
$1B buyback potential and focused on its smokable products' robust pricing strategy during Q4 earnings. However, Morgan Stanley lowered its price target for Altria, causing the stock to slide. The group is making progress in the smoke-free segment while facing challenges in smokable products. Multiple financial advisors and institutions have raised their holdings in Altria while others have reduced theirs. Altria plans to release more earnings on Thursday, and the group's Q4 2024 earnings call highlighted an EPS beat, with revenue surging to
$5,974 million. Despite these successes, the shift in focus to e-vapor and nicotine pouches, its high-yielding dividends, and a leadership change gained investor attention. Altria is competing with an illicit vape market worth
$8B, affecting its stock position. The group's E-vapes are also called out as counterfeit, contributing further to challenges in the market.
Altria Group MO News Analytics from Wed, 18 Sep 2024 07:00:00 GMT to Sat, 01 Feb 2025 16:53:26 GMT -
Rating 6
- Innovation 0
- Information 9
- Rumor -2
